coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Sale Central PCN, Trafford (LAD) · Health Inequalities Profile

    PCN U83990 · NHS Greater Manchester Integrated Care Board · 5 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    64,491

    Registered population

    59.3% aged 18–64

    18.6%

    Aged 65+

    ICB 14.9% · England 17.9%

    14.6%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~8,845

    Core20 residents (est.)

    Resident basis; registered basis ~9,555 · see page 3

    10,211

    Hypertension register

    +4.46% in 3 yrs · England +5.60%

    692

    SMI register

    25.8% of Trafford (LAD)'s

    1,285

    COPD register

    Reviews -5.21% in 3 yrs

    Forecast to 2030

    11,209

    Hypertension patients, 2030

    +998 on today

    72.1%

    QRISK ≥20% on statins, 2030

    +3.06pp over 3 yrs

    5.0%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    19
    Three-year review and blood pressure control lags.

    Of 25 measures, 19 trail England's three-year change: heart failure reviews fell 2.9%, COPD reviews fell 5.2%, and under-80 BP control fell 0.7%.

    77.1%
    Strong cancer screening and heart failure reviews.

    Cervical screening aged 25-49 reaches 77.1% (England 66.8%), breast screening reaches 75.1% (England 69.9%), and heart failure reviews reach 80.7% (England 78.5%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Aged 0-17 (22.1%) and 65+ (18.6%) list shares both exceed England benchmarks

    Across five member practices totalling 64,491 registered patients, children aged 0-17 represent 22.1% (14,243 patients), exceeding Trafford (21.8%), the ICB (21.8%) and England (19.6%). Older adults aged 65+ make up 18.6% (11,980 patients), above Trafford (17.1%), the ICB (14.9%) and England (17.9%), while adults aged 18-64 form 59.3% (38,268). In Census resident estimates, Gypsy or Irish Traveller residents comprise 0.0% (Trafford 0.0%, ICB 0.1%, England 0.1%) and Roma 0.1% (Trafford 0.1%, ICB 0.1%, England 0.2%). Unverified projections indicate 0.4% list growth to 2030 (Trafford 0.3%, ICB 1.6%, England 2.3%).

    Age profile

    0–1722.1%
    18–6459.3%
    65+18.6%

    65+: ICB 14.9%, England 17.9%

    Older people · falls rows are Trafford (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Trafford LA)2,0872,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)87.1%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)60.7%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Trafford LA)9501,0219552024/25
    Falls deaths, all ages, per 100,000 (Trafford LA)22.718.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    PCN Core20 share is 14.6%, but practice concentration spans 42.0 pp

    Sale Central PCN's Core20 share is 14.6%, above Trafford's 8.2% but below England's 21.0% and the ICB's 40.7%. Practice Core20 concentration spans 42.0 pp across the PCN: Boundary House Medical Centre records 42.05% (4,658 estimated patients), Firsway Health Centre has 20.94% (3,173 patients), and Washway Road Medical Centre records 0.0%. Resident Core20 estimates of 8,845 do not match practice-modelled totals summing to 9,555. Concentration of Core20 patients in Boundary House Medical Centre and Firsway Health Centre highlights where targeted health equity initiatives would reach the largest cohorts.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Boundary House42.0% · 4,658 patients
    Firsway20.9% · 3,173 patients
    Bodmin Road10.2% · 892 patients
    Conway Road6.1% · 832 patients
    Washway Road0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    692

    SMI register

    1.06% recorded prevalence

    313

    Learning disability register

    0.48% recorded prevalence

    23

    Care homes, 558 beds

    In the PCN catchment

    8.7%

    Provide unpaid care

    Trafford (LAD), Census 2021

    The SMI register records 692 patients (1.1%; Trafford 1.1%, ICB 1.1%, England 1.0%) and learning disability 313 (0.5%; Trafford 0.5%, ICB 0.6%, England 0.6%). Catchment services include 23 care homes (558 beds). Borough data shows an 8.7% unpaid care ceiling (5,611) and 8 rough sleepers in autumn 2025. Lower recorded learning disability prevalence than England (0.6%) may reflect differing recording practices, which clinical audit could test.

    Severe mental illness: physical health checks

    SMI health checks show blood pressure recorded at 90.3% (England 83.4%) and BMI at 89.5% (England 82.1%). Blood pressure check three-year gains rose +2.4 pp (England +4.4 pp).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    10,211

    Hypertension register

    +4.46%

    Register growth, 3 yrs

    Trafford (LAD) +4.39% · England +5.60%

    −0.50pp

    BP control, under 80

    ≤140/90 · +3.76pp aged 80+

    +998

    More patients by 2030

    Forecast 11,209 (16.99%)

    Hypertension case-finding and control

    Sale Central PCN records 10,211 hypertension patients (15.6% prevalence; England 15.2%, Trafford 15.1%). Among patients with hypertension, 93.0% had a recent blood pressure check (England 90.0%). For patients aged under 80, blood pressure control is 67.7% (England 67.8%) and fell 0.7% over three years (England +3.2%). Control for patients aged 80 and over rose +4.6% to 85.2% (England 81.2%). Across 830 heart failure patients, reviews reached 80.7% (England 78.5%), though reviews fell 2.9% over three years (England +8.7%). Slower three-year progress in blood pressure control for younger cohorts and heart failure reviews could reflect recall pressures.

    Lipids and statins

    Among patients with QRISK at or above 20%, lipid-lowering therapy coverage is 65.5% (England 63.6%, Trafford 67.1%). For patients with chronic kidney disease, lipid-lowering therapy coverage is 70.2% (England 70.3%, Trafford 71.2%). Coverage trails borough benchmarks, indicating potential to expand primary prevention reviews across high-risk patients.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026121,407£2.20£1.94£1.86£267,095
    Cardiovascular (all), 2025171,306£2.82£3.15£3.33£483,083

    In 2026, the PCN prescribed 121,407 items for lipid-regulating drugs at £2.20 per item, compared with £1.86 in England, £1.98 in Trafford, and £1.94 in the ICB. Across these items, the PCN spends £41,278 more than at England's unit cost. Unit-cost differences could reflect formulary choices or medication mix, warranting a local prescribing review.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +0.11%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −1.68%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 2.0% (1,285 patients; NHS Greater Manchester Integrated Care Board 2.3%), but reviews fell 5.2% over three years (England +2.8%) to 75.6% (England 76.4%). Asthma prevalence is 7.5% (4,664 patients; England 6.6%); reviews rose 0.1% over three years (England +4.4%) to 69.7% (England 65.7%), leaving an unreviewed scale indicator of 1,413 patients. Second-hand smoke recording for asthma patients aged 6-19 is 71.6% (England 78.8%). Three-year review lags may indicate capacity constraints in routine respiratory follow-up.

    Cancer register and children's immunisation

    Cancer prevalence is 4.5% (2,944 patients; England 3.8%), with three-year growth of +5.7% (England +9.0%). In Q1 2025/26 childhood immunisations at age 5, MMR dose 1 reached 95.3%, while MMR dose 2 was 90.1% (5.2 pp below dose 1 and below the 95.0% target by 4.9 pp). The 4-in-1 booster reached 86.6%, below the 95.0% target by 8.4 pp. Booster coverage lags behind first-dose uptake across pre-school cohorts.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months90.8%

    England 91.0%

    6-in-1 complete primary course at 24 months97.5%

    England 92.2%

    MMR dose 1 at 24 months93.2%

    England 88.3%

    MMR dose 2 at age 590.1%

    England 82.8%

    4-in-1 pre-school booster at age 586.6%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    In NHS Greater Manchester ICB in 2022, 55.6% of cancers with a known stage (6,491 of 11,679) were diagnosed at stage 1 or 2, compared to England (55.3%) and 19.4 pp below the 75.0% national ambition. Known stage was recorded for 70.8% of registered cancers (11,679 of 16,492; England 67.0%). Reaching the ambition across the ICB would require about 2,270 additional early-stage diagnoses annually based on 2022 staged cases. In Sale Central PCN, recorded cancer prevalence is 4.5% (2,944 patients), with three-year register growth of +5.7% trailing England (+9.0%) and Trafford (+7.8%).

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026 (provisional), Manchester University NHS Foundation Trust achieved 72.8% on the 62-day cancer referral to treatment standard, trailing Northern Care Alliance NHS Foundation Trust (78.6%), Stockport NHS Foundation Trust (74.7%) and NHS Greater Manchester Integrated Care Board (75.7%), but exceeding England (71.2%) while sitting 12.2 pp below the 85.0% standard. For six-week diagnostic waits, Manchester University NHS Foundation Trust recorded 14.7% for CT (Stockport 2.9%, Northern Care Alliance 4.1%, England 9.9%) and 11.7% for MRI. These provider metrics reflect wider acute system activity rather than direct PCN performance.

    Pathways within standard (%)ManchesterNorthern Care AllianceStockportGreater Manchester ICBEngland
    28-day faster diagnosis (75%)80.0675.2083.2179.5379.32
    31-day treatment (96%)92.5494.5497.3996.4992.50
    62-day referral to treatment (85%)72.8578.6574.6775.7371.16
    Diagnostic waits over 6 weeks (%)ManchesterNorthern Care AllianceStockportEngland
    MRI11.685.091.4121.40
    CT14.664.102.939.92
    Echocardiography4.9131.4817.4628.48
    Colonoscopy4.5140.045.5330.83
    Gastroscopy29.3536.485.3129.02
    All 15 DM01 tests8.9815.7114.0823.14
    Community services activityTrafford residentsGreater Manchester ICB
    Care contacts41,705573,310
    Referrals7,44594,470
    Patients with a contact13,840183,535

    Community services (residents of Trafford), Jun 2026 (provisional). In June 2026 (provisional), community health service contacts for Trafford borough residents totalled 41,705, of which 21,375 (51.3%) were with adults aged 65 and over. These figures describe local authority resident contacts rather than PCN-level provision.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Vaccination domain achievement varies by 27.4 pp across member practices in 2025/26

    In 2025/26, overall QOF achievement ranges from 92.0% at Bodmin Road Health Centre to 98.2% at Conway Road Medical Practice (England 92.5%). Vaccination and immunisation achievement varies by 27.4 pp, from 57.1% at Boundary House Medical Centre to 84.5% at Conway Road Medical Practice (England 55.2%), which may reflect differing recall or uptake dynamics requiring local audit.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Boundary House10242.088.7%74.2%90.4%
    Washway Road1040.079.8%78.6%87.5%
    Conway Road986.184.6%86.0%85.9%
    Bodmin Road10710.272.1%83.9%82.9%
    Firsway11620.962.2%82.5%78.2%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNTrafford (LAD)AssetPCNTrafford (LAD)
    Care homes (catchment)23 (558 beds)n/aSchools (catchment)46n/a
    Children's centres516Places of worship25119
    Libraries29Primary schools (LA maintained)1439
    Primary academies517Special schools23

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma review and smoke recording

    Asthma review coverage is 69.7% across 4,664 patients (+0.1% 3-year change vs England +4.4%), leaving a 1,413-patient unreviewed scale estimate; age 6-19 second-hand smoke recording is 71.6% (England 78.8%). For discussion: run a single-template asthma recall and inhaler review with after-school slots for ages 6-19, starting in high-Core20 practices. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Under-80 hypertension control and lipid review

    Under-80 BP control is 67.7% (England 67.8%), falling 0.7% (0.5 pp) over 3 years (England +3.2%, +2.1 pp). Lipid-modifying drugs cost £2.20 per item vs £1.86 in England (£41,278 more across 121,407 items). For discussion: deploy pharmacist-led recall for under-80 hypertension patients above target alongside a formulary and statin review. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 3

    Learning disability register coding validation

    Learning disability prevalence is 0.5% (313 patients, 26% of Trafford's register, +8.2% 3-year change), matching Trafford (0.5%) but 0.1 pp below England and the ICB (0.6%), giving a -1 to +66 benchmark range. Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Dual cohort capacity planning (p2)Aged 0-17Medium Term Planning Framework 2026 · Neighbourhood health frameworkPCN
    Targeted Core20 practice outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI health check recall audit (p4)Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension recall audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Preschool immunisation booster recall (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cancer register review and audit (p7)Cancer: QOF prevalenceCore20PLUS5, 75% stage 1–2 by 2028PCN
    Option 1 · Structured asthma review and smoke recording (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Patients with Asthma (6-19 yrs): Second-hand smoking status recorded in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Under-80 hypertension control and lipid review (p12)Hypertension register · Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) · Cost per item for Lipid-regulating drugs 2026Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 3 · Learning disability register coding validation (p12)Registered population · Learning disability register · Learning disability: QOF prevalence75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15